Pulmonary Syrup in pharma franchise in Rajasthan

Pulmonary Syrup in PCD pharma franchise in Kolkata

Pulmonary Syrup in top pharma company in Manipur

Pulmonary Syrup in pcd pharma supplier in Kerala

Pulmonary Syrup in phama franchise company in India
Pulmonary Syrup in phama distributor in Kohima

Home/Products /levodropropizine-i-point-p-point-30mg-syrup

Cufsniff LD Syrup

Composition : Levodropropizine I.P. 30mg + Chlorpheniramine I.P. 2mg syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 100ml

Price : ₹119/-

Cufsniff CS Syrup is a specialized formulation designed to provide effective relief from cough and associated symptoms. Each dose of this syrup contains Levodropropizine (30 mg), a non-opioid antitussive agent, and Chlorpheniramine (2 mg), an antihistamine. This combination works synergistically to alleviate cough while addressing underlying allergic symptoms, making it an ideal choice for individuals suffering from respiratory discomfort due to colds, allergies, or other irritants.

Levodropropizine acts by selectively inhibiting the cough reflex without suppressing the respiratory drive, allowing for effective cough control. It is particularly beneficial for managing dry, non-productive coughs, providing relief without the sedative effects commonly associated with other cough suppressants.

Chlorpheniramine, on the other hand, is an antihistamine that helps reduce allergy-related symptoms such as sneezing, runny nose, and itchy throat. By alleviating these symptoms, Chlorpheniramine enhances the overall effectiveness of the syrup in providing comfort during respiratory illnesses.

Cufsniff CS Syrup is easy to administer and is suitable for both adults and children, making it a versatile option for families. Its palatable formulation ensures that it can be taken without difficulty, promoting adherence to the treatment regimen.

Read More

About the Product

Cufsniff CS Syrup is a specialized formulation designed to provide effective relief from cough and associated symptoms. Each dose of this syrup contains Levodropropizine (30 mg), a non-opioid antitussive agent, and Chlorpheniramine (2 mg), an antihistamine. This combination works synergistically to alleviate cough while addressing underlying allergic symptoms, making it an ideal choice for individuals suffering from respiratory discomfort due to colds, allergies, or other irritants.

Levodropropizine acts by selectively inhibiting the cough reflex without suppressing the respiratory drive, allowing for effective cough control. It is particularly beneficial for managing dry, non-productive coughs, providing relief without the sedative effects commonly associated with other cough suppressants.

Chlorpheniramine, on the other hand, is an antihistamine that helps reduce allergy-related symptoms such as sneezing, runny nose, and itchy throat. By alleviating these symptoms, Chlorpheniramine enhances the overall effectiveness of the syrup in providing comfort during respiratory illnesses.

Cufsniff CS Syrup is easy to administer and is suitable for both adults and children, making it a versatile option for families. Its palatable formulation ensures that it can be taken without difficulty, promoting adherence to the treatment regimen.

Common side effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances. Some individuals may experience allergic reactions; monitoring for unusual symptoms is advised.

Cufsniff CS Syrup is indicated for the relief of cough associated with colds and allergic conditions.

Cufsniff CS Syrup should be used as directed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms persist or worsen.

Store Cufsniff CS Syrup in a cool, dry place, away from direct sunlight. Ensure the cap is tightly closed after use and keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation